Stay updated on Selpercatinib in Advanced Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selpercatinib in Advanced Solid Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The website revision tag was updated from v3.5.3 to v3.5.4, indicating a small deployment update to the page’s framework. It does not imply changes to the study information shown on the page.
    Difference
    0.0%
    Check dated 2026-05-18T03:43:52.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    A new publication citation was added to the Publications section, detailing a 2024 Oncologist article on selpercatinib's long-term safety and related RET-activated tumors.
    Difference
    0.0%
    Check dated 2026-05-04T01:17:04.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    ClinicalTrials.gov’s study details page now reflects a newer software/content release revision (v3.5.3 instead of v3.5.2), without changing any study-specific information.
    Difference
    0.0%
    Check dated 2026-04-26T15:22:11.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    Results status changed from 'Results Submitted' (2025-10-20) to 'Results Posted' (2026-04-16), with added text describing the LIBRETTO-001 trial results and phase 2 cohorts. The update indicates public availability of the study results and related documentation.
    Difference
    6%
    Check dated 2026-04-19T13:39:32.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Medullary thyroid carcinoma term added to the study conditions. Genetic and Rare Diseases Information Center resources added.
    Difference
    0.1%
    Check dated 2026-03-28T23:53:09.000Z thumbnail image
  9. Check
    73 days ago
    Change Detected
    Summary
    Revision: v3.5.0; Revision: v3.4.3 removed. The update appears to be an internal version bump with no visible changes to the study page content in the provided screenshots.
    Difference
    0.0%
    Check dated 2026-03-21T16:12:03.000Z thumbnail image

Stay in the know with updates to Selpercatinib in Advanced Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.